IP Library Granted Patent US 9,125,430
Granted Patent B2
US 9,125,430 · App. 12/376,662 · Granted Sep 8, 2015

Stable and bioavailable compositions of isomers of carotenoids for skin and hair

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,125,430
App. No.
12/376,662
Granted
Sep 8, 2015
Kind
B2
Abstract

Compositions that provide health benefits and methods regarding same are presented. In an embodiment, the present invention provides a primary composition comprising at least one carotenoid-containing material, enriched in Z isomers of the carotenoid compound. For example, the carotenoid-containing material contains by weight a greater percentage of an isomer selected from the group consisting of 5-Z, 9-Z and combinations thereof than of 13-Z isomer.

Claims (12)

1. A stable primary composition comprising at least one carotenoid-containing material is an oleoresin comprising a carotenoid content from 0.05% to 50% by weight, is enriched in Z isomers of the carotenoid compound, and comprises by weight of a total carotenoid content a greater percentage of an isomer selected from the group consisting of 5-Z, 9-Z and combinations thereof than of a 13-Z isomer, and contains more than 30% by weight of the total carotenoid content of the isomer selected from the group consisting of 5-Z, 9-Z and combinations thereof, and less than 10% by weight of the total carotenoid content of the 13-Z isomer, and the Z:E isomer ratio of the carotenoid compound is between 20:80 and 95:5.

2. The primary composition of claim 1 , comprising a content in E isomer that is not greater than 60% of the total carotenoid content.

3. The primary composition of claim 1 , wherein the Z isomers of the carotenoid compound are present in an amount effective to increase the bioavailability and/or bioefficacy of the carotenoid compound.

4. The primary composition of claim 1 , wherein the carotenoid compound is selected from the group consisting of lycopene, carotenes, zeaxanthine, astaxanthine, β-cryptoxanthin, capsanthine, canthaxanthine, lutein, phytofluene, phytoene and combinations thereof.

5. The primary composition of claim 1 , wherein the Z/E isomer ratio of the carotenoid compound is from 30:70 to 90:10.

6. The primary composition of claim 1 , wherein the composition is in a form selected from the group consisting of liquid, gel and powder.

7. The primary composition of claim 1 , wherein the isomer selected from the group consisting of 5-Z, 9-Z and combinations thereof comprises 5-Z isomer.

8. The primary composition of claim 1 , wherein the isomer selected from the group consisting of 5-Z, 9-Z and combinations thereof comprises 9-Z isomer.

9. The primary composition of claim 1 , wherein the isomer selected from the group consisting of 5-Z, 9-Z and combinations thereof comprises both 5-Z and 9-Z isomers.

10. The primary composition of claim 1 , wherein the amount of the 13-Z isomer is less than 3% by weight of the total carotenoid content.

11. An oral composition comprising between about 10 and 50% by weight of a primary composition comprising at least one carotenoid-containing material in a form selected from the group consisting of an extract, a concentrate and an oleoresin, enriched in Z isomers of the carotenoid compound, the carotenoid-containing material comprises by weight of a total carotenoid content a greater percentage of an isomer selected from the group consisting of 5-Z, 9-Z and combinations thereof than of a 13-Z isomer, and contains more than 30% by weight of the total carotenoid content of the isomer selected from the group consisting of 5-Z, 9-Z and combinations thereof, and less than 10% by weight of the total carotenoid content of the 13-Z isomer, and the Z:E isomer ratio of the carotenoid compound is between 20:80 and 95:5.

12. A stable primary composition comprising at least one carotenoid-containing material in a form selected from the group consisting of an extract, a concentrate and an oleoresin, enriched in Z isomers of the carotenoid compound, the carotenoid-containing material comprises by weight of a total carotenoid content a greater percentage of an isomer selected from the group consisting of 5-Z, 9-Z and combinations thereof than of a 13-Z isomer, and contains more than 30% by weight of the total carotenoid content of the isomer selected from the group consisting of 5-Z, 9-Z and combinations thereof, and less than 10% by weight of the total carotenoid content of the 13-Z isomer, and the Z:E isomer ratio of the carotenoid compound is between 20:80 and 95:5, wherein the amount of the isomer selected from the group consisting of 5-Z, 9-Z and combinations thereof is more than 50% by weight of the total carotenoid content.

Assignments (4)
CORRECTIVE ASSIGNMENT TO CORRECT THE PATENT NUMBER 16062921 PREVIOUSLY RECORDED ON REEL 049391 FRAME 0756. ASSIGNOR(S) HEREBY CONFIRMS THE PATENT NUMBER SHOULD HAVE BEEN 16062912. Recorded Jul 3, 2020
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 054082/0001 →
CORRECTIVE ASSIGNMENT TO CORRECT THE PATENT NUMBER 16062921 PREVIOUSLY RECORDED ON REEL 049391 FRAME 0756. ASSIGNOR(S) HEREBY CONFIRMS THE PATENT NUMBER SHOULD HAVE BEEN 16062912. Recorded Jul 3, 2020
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 054082/0165 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ENGLISH TRANSLATION TO SHOW THE FULL AND CORRECT NEW NAME IN SECTION 51. PREVIOUSLY RECORDED AT REEL: 049391 FRAME: 0756. ASSIGNOR(S) HEREBY CONFIRMS THE MERGER. Recorded Jun 13, 2019
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 049853/0398 →
MERGER Recorded Jun 6, 2019
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 049391/0756 →